Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC22037	Bobcat339 Featured	Bobcat339 (Bobcat 339) is a novel cytosine-based TET enzyme inhibitor with IC50 of 33 uM (TET1) and 73 uM (TET2), but not DNMT3a, does not inhibit the DNA methyltransferase DNMT3a.
DC23218	BOC-D-FMK Featured	BOC-D-FMK is a cell-permeable, irreversible, broad spectrum caspase inhibitor, inhibits apoptosis stimulated by TNF-α with IC50 of 39 uM.
DC5077	Boceprevir(EBP 520; SCH 503034 ) Featured	Boceprevir(EBP 520; SCH 503034 ) is useful for Anti HCV.
DC8073	Bohemine Featured	Bohemine is a synthetic, cell-permeable, cyclin-dependent kinase inhibitor.
DC1027	Bortezomib (Velcade,MG-341,PS-341) Featured	Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM.
DC21869	Borussertib Featured	Borussertib is a potent, first-in-class, covalent-allosteric AKT inhibitor.
DC12405	BOS172722 Featured	BOS172722 (BOS-172722) is a potent, selective MPS1 kinase inhibitor with biochemical IC50 of 11 nM, 100-fold selectivity over CDK2.
DC5164	Bosutinib (SKI-606) Featured	Bosutinib is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity.
DC8040	STAT3 Inhibitor XVIII, BP-1-102 Featured	BP-1-102 is a potent, orally bioavailable and selective STAT3 inhibitor.BP-1-102 could enhance the transfection efficiency to 2-fold to 5-fold of Lipofectamine 3000 and LNP, all of which are currently approved for clinical use in the treatment of the most common malignant tumors.
DC8883	BP897 Featured	BP897 is a partially selective D3 dopamine receptor agonist.
DC12608	BPN14770 Featured	BPN14770 (BPN-14770) is an allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 and 7.4 nM for human PDE4D7 and PDE4D3 respectively, displays 16-fold less potent against monomeric form of PDE4D lacking the UCR1 dimerization domain (PDE4D2
DC8294	BPR1J-097 Featured	BPR1J-097 is a novel small molecule FLT-3 inhibitor(IC50=11±7 nM) with promising in vivo anti-tumour activities; inhibits FLT-3 D835Y with an IC50 of 3 nM.
DC7951	Glutaminase Inhibitor II, BPTES Featured	BPTES is a selective inhibitor of Glutaminase GLS1 (KGA)
DC10618	BPTU Featured	BPTU is an Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM).
DC8392	BQ-123 Featured	BQ-123 is a selective endothelin A receptor (ETA) antagonist with IC50 of 7.3 nM. Phase 2.
DC7542	BQ-788 Featured	BQ-788 sodium salt is a potent, selective ETB receptor antagonist (IC50 = 1.2 nM for inhibition of ET-1 binding to human Girardi heart cells); poorly inhibited the binding to ET A receptors in human neuroblastoma cell line SK-N-MC cells (IC(50), 1300 nM).
DC10515	BQCA Featured	BQCA is a potent muscarinic M1 receptor positive allosteric modulator with selectivity for M1 over M2-M5.
DC8202	BQU57 Featured	BQU57 is a potent and selective GTPase Ral Inhibitor.
DC7809	BRACO19 trihydrochloride Featured	BRACO19 is a telomerase inhibitor that stabilizes G-quadruplexes, targeting telomeric G-quadruplexes, inducing DNA damage and cell-cycle arrest.
DC20323	Bractoppin Featured	Bractoppin is a potent, small-molecule chemical inhibitor that specific selectively blocks phosphopeptide recognition by the BRCA1 tBRCT domain with binding IC50 of 74 nM; shows no inhibition for recognition of cognate biotinylated phosphopeptides to the TOPBP1 tBRCT 7/8, or GRB2 SH2 proteins; engages BRCA1 tBRCT residues recognizing pSer in the consensus motif, pSer-Pro-Thr-Phe, plus an abutting hydrophobic pocket; inhibits substrate recognition detected by Förster resonance energy transfer, and diminishes BRCA1 recruitment to DNA breaks, in turn suppressing damage-induced G2 arrest and assembly of the recombinase, RAD51; selectively interrupts BRCA1 tBRCT-dependent signals evoked by DNA damage.
DC7775	Bradanicline (TC-5619) Featured	Bradanicline (TC-5619) is an experimental pharmaceutical drugthat acts as a partial agonist at the α7 subtype of the neural nicotinic acetylcholine receptors.
DC7718	B-Raf IN 1 Featured	B-Raf IN 1 is a highlt potent and selective B-Raf inhibitor with IC50 of 24 nM; equipotent against c-Raf (IC50= 25 nM).
DC8921	B-Raf inhibitor 1 Featured	B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 uM and 2 nM for A375 proliferation and A375 p-ERK respectively.
DC7008	BRAF inhibitor Featured	BRAF inhibitor is a potent BRAF inhibitor.
DC12375	Bragsin2 Featured	Bragsin2 is a novel PH-domain-binding inhibitor,inhibiting BRAG2-mediated Arf GTPase activation.
DC7097	Cebranopadol(GRT-6005) Featured	branopadol(GRT-6005) is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor.
DC9839	Brassinin Featured	Brassinin is a Inducer of phase II enzymes. Moderate and competitive indoleamine 2,3-dioxygenase inhibitor (Ki = 98 μM). Shows chemopreventive effects in vivo. Orally active.
DC23100	Brassinolide Featured	Brassinolide is a predominant plant growth modulator that regulate plant cell elongation. It is active against herpes and arena viruses.
DC12221	BRD 4354 Featured	BRD 4354 is a moderately potent inhibitor of HDAC5 and HDAC9, with IC50s of 0.85 and 1.88 μM, respectively.
DC20842	BRD 7389 Featured	BRD 7389 is an inhibitor of ribosomal S6 kinases (RSK) with IC50 of 1.5 uM, 2.4 uM, and 1.2 uM for RSK1, RSK2, and RSK3, respectively.

Featured products

Customized Consultation X

Your information is safe with us. * Required Fields.